Remove CBD Remove DEA Remove Extraction
article thumbnail

Intoxicating Hemp Swindle

Project CBD

Explains Devitt: If Im going to extract or source Delta-9 THC from hemp rather than [high-resin] cannabis, Im going to need around 50 times more biomass, which means 50 times more acreage, 50 times more labor, 50 times more water, et cetera, et cetera, [to make a small amount of THC distillate.] Hemp not really hemp Speaking in a Feb.

Hemp 230
article thumbnail

Doctor Sues DEA for Right to Give Psilocybin to Ailing Patients

Project CBD

Psilocybin, the psychedelic mushroom extract, has been fast-tracked by the FDA to treat depression, but doctors still can’t use it in their practice.

DEA 348
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 194
article thumbnail

10 Tips for Buying Hemp-Derived CBD Products

Project CBD

With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate?

Hemp 206
article thumbnail

FDA Approves CBD-Containing Drug - Will the DEA Finally Step Up?

MJ Business Attorneys

Food and Drug Administration (FDA) approved Epidiolex, a drug containing Cannabidiol (CBD). Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. As the Controlled Substances Act (CSA) currently stands, CBD is still a Schedule I substance, which classifies CBD as having no medicinal uses.

DEA 113
article thumbnail

Doctor Sues DEA for Right to Give Psilocybin to Dying Patients

Project CBD

Psilocybin, the psychedelic mushroom extract, has been fast-tracked by the FDA to treat depression, but doctors still can’t use it in their practice.

DEA 150
article thumbnail

The Week in Weed: October 30, 2020

The Blunt Truth

New York releases new CBD regulations, and Governor Cuomo supports legal cannabis. Oregon Senators voice their opposition to the DEA’s hemp rule. New York State released proposed rules for hemp extracts in food, drinks and vapes this week. dea hemp rule. Five states have marijuana on the ballot this year.

DEA 116